Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Tagrisso for first-line NSCLC

April 19, 2018

Fasenra for asthma now available in Japan

April 19, 2018

AstraZeneca launches Lynparza in Japan

April 19, 2018

Caspid modulator GLP-26 shows promise for drug-resistant hepatitis B virus infection

April 19, 2018

FDA grants fast track designation CB-839 in combination with cabozantinib for treatment of RCC

April 19, 2018

Preclinical evaluation of novel HERA-LIGHT fusion protein for cancer immunotherapy

April 19, 2018

Artelo Biosciences licenses IP portfolio of fatty acid binding protein inhibitors

April 19, 2018

AntoXa Corporation obtains license from DRDC for plant-made PhD9 anti-ricin antibody

April 19, 2018

First subject dosed in phase I/IIa trial of SYNB-1618 for the treatment of phenylketonuria

April 19, 2018

Bayer presents a novel SMYD3 inhibitor probe

April 19, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...